Fractyl Health
MA - BurlingtonBiotechnology
Focus: Fractyl Health is a clinical-stage biotech company focused on thermal ablation therapy and gene therapy, with a pipeline centered on duodenal mucosal resurfacing (DMR) for metabolic diseases including Type 2 diabetes, obesity, and NASH. The company is publicly traded (NASDAQ: GUTS) and based in Burlington, MA.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Open Jobs
1
Should You Work at Fractyl Health?
AI assessmentFractyl Health is a speculative mid-cap play with one promising near-term catalyst (Revita® DMR pivotal data) but very limited hiring and unclear pathway to commercialization; best suited for early-stage biotech specialists comfortable with higher execution risk in exchange for potential equity upside.
Why Work Here
- Early-stage commercial opportunity: Company recently completed randomization in REMAIN-1 pivotal cohort for Revita® DMR (Feb 2026), signaling near-term catalyst potential for a novel procedural therapy in high-growth metabolic disease markets.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Duodenal Mucosal Resurfacing
Type 2 DiabetesClinical Trials (1)
NCT04419779Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes
N/AHelp build intelligence for Fractyl Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.